EXLS in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with EXLS today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
ExlService Holdings, Inc., known as EXL, helps businesses process information and carry out day-to-day work such as handling insurance claims and checking healthcare payments. Clients pay EXL both to build data and AI into their workflows and to run business functions using its teams and technology. Data and AI-led work generates more revenue than managed operations, but both are substantial parts of the business.
Insurance is its largest customer industry. Insurers hire EXL for work ranging from underwriting support to policy administration and claims management. Healthcare organizations pay it to check payments, manage care and collect money owed for services; banks and other businesses also buy its analytics and operational services. Most revenue comes from serving customer operations in North America. EXL charges according to the work or staffing supplied, transactions processed, subscriptions, or outcomes such as client usage or savings.
A limited group of large clients supplies a substantial share of revenue, although no single client dominates. Continued revenue depends on clients retaining and assigning work: most contracts can be ended without cause and do not guarantee a volume of business. Because EXL handles sensitive health and financial information, privacy and data-localization laws constrain how it processes and stores client data.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
EXL depends on enterprise demand for AI-led analytics and outsourced operations, while privately held Cotiviti is also a key competitor to watch in checking healthcare payments for errors.
Genpact competes with EXL for banks’ and insurers’ spending on running and automating business processes and applying data and AI. Its Financial Services revenue is the line to watch for demand from these shared customer groups.
Cognizant competes with EXL to run business processes and modernize workflows with AI for healthcare and financial-services clients. Watch its work for these clients rather than treating all of its technology services as a match for EXL.
Infosys competes with EXL for enterprise spending on running business processes, analyzing data and putting AI into workflows. Its data, analytics and AI services are a closer comparison for EXL than its broader software and infrastructure work.
Accenture competes with EXL for enterprise budgets for AI-led transformation, analytics and outsourced operations. Its work running client operations under Managed Services is the clearest comparison with EXL’s digital operations business.
Concentrix Corporation competes with EXL to handle customer service, finance and compliance work, and related analytics, for business clients. Its customer-support and renewal operations are concrete areas to watch for overlap with EXL’s customer-service work.
Claritev Corporation competes with EXL to help healthcare payers spot improper charges and reduce medical costs through claims checks and analytics. Watch its work for self-insured health plans, which accounted for over 84.5% of its 2025 revenue.
SS&C Technologies Inc overlaps with EXL in using software to run outsourced operations and provide risk analytics for financial-services and healthcare clients. Its securities accounting, risk analytics and healthcare information services are the relevant areas, rather than software licensing alone.
CGI Inc. competes with EXL to run clients’ business processes and modernize them with technology, data and AI. Its managed business-process services are the closest comparison with EXL, rather than responsibility for clients’ IT systems alone.
EPAM competes with EXL for financial-services and healthcare clients’ data, analytics, AI and software-engineering projects. Its financial-technology and healthcare-technology work is the part to watch for this overlap.
Huron competes with EXL for healthcare clients’ transformation, analytics and outsourced operations work, but its substantial education business makes total revenue a less direct comparison. Healthcare contributed 50% and Education 30% of its 2025 revenue before reimbursable expenses, so watch Healthcare separately.
Conduent Incorporated’s Commercial business competes with EXL to run outsourced processes for enterprise clients; its government and transportation operations make the whole company a less direct comparison. Watch Commercial revenue, which represented 49.7% of 2025 total revenue excluding divestitures.
Guidewire competes with EXL for insurers’ spending on underwriting, policy administration, billing and claims, selling cloud software subscriptions where EXL combines technology with services. Watch subscriptions to InsuranceSuite and InsuranceNow for insurers’ demand to modernize these workflows.
XBP Global competes with EXL to run banking, healthcare and insurance workflows using automation. Its combination of AI-driven automation and staff handling exceptions is the operating model to watch alongside EXL’s technology-enabled managed services.
ExlService Holdings, Inc. earningsThis company
ExlService earns from both data and AI-led services and digital operations, and this report will show whether growth in the former is translating into a stronger gross margin.
Compare revenue growth in data and AI-led services with digital operations, then check gross margin—the share of revenue left after the direct costs of delivering services. Faster data and AI growth with a steady or rising margin would show that this work is scaling without losing control of delivery costs. Slower growth or a falling margin would show that growth is not yet translating reliably into profit. The conclusion is whether data and AI work can expand while preserving profit on each dollar of revenue.
Fed Interest Rate Decision
For ExlService, the Fed’s policy rate—the rate that guides borrowing costs across the economy—can affect what it pays on its floating-rate credit facilities and how much cash remains for its business.
Expected4.0%Last release4.0%
If it comes in above expectations
If the policy rate is above expectations, interest costs on ExlService’s floating-rate borrowings may rise, leaving less operating cash to fund its services and digital capabilities.
If it comes in below expectations
If the policy rate is below expectations, interest costs on ExlService’s floating-rate borrowings may ease, leaving more operating cash available to fund its services and digital capabilities.
GENPACT LIMITED earningsG
Genpact serves banks and insurers through its Financial Services business, and its report will show how demand for outsourced processes, automation, and data and AI work is changing among those shared customers.
Read Genpact's Financial Services revenue alongside its total revenue. Growth in both would show that banks and insurers are still paying for this kind of work, supporting demand among customers ExlService also serves while confirming active competition for their budgets. If Financial Services weakens while total revenue holds up, pressure is more concentrated in that customer work, making related opportunities harder for ExlService to win. The conclusion is whether shared customers are sustaining or tightening spending on these services.
Claritev Corporation earningsCTEV
Claritev helps self-insured health plans check claims and reduce medical costs, and its report will show how demand for that work is changing.
Watch whether Claritev's work for self-insured health plans grows, and compare it with the company's total revenue; these plans accounted for over 84.5% of its 2025 revenue. Growth in that work alongside steady total revenue would show health plans are still paying for claims checks and cost reduction, a useful demand signal for ExlService's healthcare business. If the work declines while total revenue holds up, pressure is more concentrated in these services and ExlService may face a tougher contest for related projects. The conclusion is whether health plans are sustaining or pulling back on claims-checking and cost-control work.